Matinas BioPharma

(NYSEMKT) MTNB

Current Price$0.68

Market Cap$4.51M

Since IPO (2014)-99%

5 Year-98%

1 Year-7%

1 Month+26%

Matinas BioPharma Financials at a Glance

Market Cap

$4.51M

Revenue (TTM)

$0.00

Net Income (TTM)

$11.23M

EPS (TTM)

$-2.02

P/E Ratio

-0.35

Dividend

$0.00

Beta (Volatility)

1.19 (Average)

Dividend

$0.00

Beta (Volatility)

1.19 (Average)

Price

$0.68

Volume

42,891.714

Open

$0.65

Price

$0.68

Volume

42,891.714

Open

$0.65

Previous Close

$0.70

Daily Range

$0.63 - $0.71

52-Week Range

$0.48 - $3.09

Dividend

$0.00

Beta (Volatility)

1.19 (Average)

Price

$0.68

Volume

42,891.714

Open

$0.65

Previous Close

$0.70

Daily Range

$0.63 - $0.71

52-Week Range

$0.48 - $3.09

MTNB News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Matinas BioPharma

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jerome D. Jabbour

Website

www.matinasbiopharma.com

Headquarters

Bedminster, NJ 07921, US

MTNB Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-242%

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

-2.86%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.51M

Shares Outstanding

6.41M

Volume

42.89K

Avg. Volume

131.27K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$6.96M

EBITDA

$6.50M

Operating Cash Flow

$7.01M

Capital Expenditure

$0.00

Free Cash Flow

$7.01M

Cash & ST Invst.

$4.00M

Total Debt

$1.35M

Matinas BioPharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$74.00K

+12.9%

Gross Margin

0.00%

N/A

Market Cap

$4.51M

N/A

Market Cap/Employee

$1.50M

N/A

Employees

N/A

Net Income

$1.92M

-16.0%

EBITDA

$1.86M

+3.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$1.26M

-70.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$469.00K

-75.6%

Short Term Debt

$720.00K

-9.3%

Return on Assets

-1.91%

N/A

Return on Invested Capital

-1.85%

N/A

Free Cash Flow

$1.60M

+20.2%

Operating Cash Flow

$1.60M

+20.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ADXNAddex Therapeutics Ltd

ADXNAddex Therapeutics Ltd$6.83-2.29%

KTTAPasithea Therapeutics Corp.

KTTAPasithea Therapeutics Corp.$0.70-2.94%

CDIOCardio Diagnostics Holdings, Inc.

CDIOCardio Diagnostics Holdings, Inc.$1.61+6.62%

ACXPAcurx Pharmaceuticals, Inc.

ACXPAcurx Pharmaceuticals, Inc.$1.97+2.07%

HCWBHCW Biologics Inc.

HCWBHCW Biologics Inc.$2.89+12.02%

ADILAdial Pharmaceuticals, Inc.

ADILAdial Pharmaceuticals, Inc.$2.08-9.57%

BCLIBrainstorm Cell Therapeutics Inc.

BCLIBrainstorm Cell Therapeutics Inc.$0.68-4.64%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$15.47+0.09%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

NIONio

NIONio$5.20-0.07%

INTCIntel

INTCIntel$119.84+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

INFQInfleqtion

INFQInfleqtion $16.35+0.11%

TET1 Energy Inc.

TET1 Energy Inc.$8.08-0.07%

Questions About MTNB

What is the current price of Matinas BioPharma?

Matinas BioPharma is trading at $0.70 per share.

What is the 52-week range for Matinas BioPharma?

Over the past 52 weeks, Matinas BioPharma has traded between $0.48 and $3.09.

How much debt does Matinas BioPharma have?

As of the most recent reporting period, Matinas BioPharma reported total debt of $1.19M.

How much cash does Matinas BioPharma have on hand?

Matinas BioPharma reported $2.45M in cash and cash equivalents in its most recent financial results.

What is Matinas BioPharma’s dividend yield?

Matinas BioPharma does not currently have a dividend yield.

Matinas BioPharma

Matinas BioPharma Financials at a Glance

MTNB News

Why Matinas BioPharma Stock Crashed Today

Why Matinas BioPharma Holdings Shot Almost 28% Higher Today

Here's Why Matinas Biopharma Shares Fell as Much as 23.6% Today

Here's Why Matinas BioPharma Shares Lost as Much as 16.9% Today

Why Matinas BioPharma Tumbled 13.4% Today

Here's Why Matinas BioPharma Holdings Inc. Is Losing Ground Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Matinas BioPharma

MTNB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Matinas BioPharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MTNB

What is the current price of Matinas BioPharma?

What is the 52-week range for Matinas BioPharma?

How much debt does Matinas BioPharma have?

How much cash does Matinas BioPharma have on hand?

What is Matinas BioPharma’s dividend yield?

Premium Investing Services